Literature DB >> 15225584

Making sense of sex and supplements: differences in the anticarcinogenic effects of selenium in men and women.

David J Waters1, Emily C Chiang, Dawn M Cooley, J Steven Morris.   

Abstract

The role of the essential trace mineral selenium in human health and disease is currently a subject of intense interest. In particular, the possible cancer preventive effects of dietary selenium supplementation are now being investigated in several large, randomized trials. The association between selenium status, genotoxic damage, and cancer risk remains enigmatic because epidemiologic studies have failed to consistently link low selenium status with increased cancer risk in men and women. In this paper, we considered the evidence that there are sex-based differences in the anticarcinogenic effects of selenium in humans. We focused our review on prospective human studies in which the relationship between selenium status and cancer risk in men and women was directly compared. Results from cohort studies conducted in seven countries (Belgium, China, Finland, Japan, Netherlands, Norway, and United States) were used to assess the strength of association between low selenium status and the incidence of all cancers, sex-specific cancers, and cancers at particular anatomic sites. In general, the available data support the hypothesis that cancer risk in men is more profoundly influenced by selenium status than cancer risk in women. Factors contributing to the apparent difference in the effects of selenium on cancer incidence in men and women may include sex-based differences in the metabolism and/or tissue distribution of selenium, as well as sex- or gender-related factors that influence tumor biology. Studies are needed to further define the dose-response relationship between selenium and cancer risk in men and women. A more complete understanding of the mechanisms by which selenium modulates cancer initiation and progression is needed to optimize dietary selenium supplementation as a practical cancer preventive strategy. Ultimately, achieving the ambitious goal of cancer prevention may require sex- and gender-specific approaches.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15225584     DOI: 10.1016/j.mrfmmm.2004.02.019

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  15 in total

Review 1.  Selenium for preventing cancer.

Authors:  Marco Vinceti; Gabriele Dennert; Catherine M Crespi; Marcel Zwahlen; Maree Brinkman; Maurice P A Zeegers; Markus Horneber; Roberto D'Amico; Cinzia Del Giovane
Journal:  Cochrane Database Syst Rev       Date:  2014-03-30

2.  Serum selenium, genetic variation in selenoenzymes, and risk of colorectal cancer: primary analysis from the Women's Health Initiative Observational Study and meta-analysis.

Authors:  Yumie Takata; Alan R Kristal; Irena B King; Xiaoling Song; Alan M Diamond; Charles B Foster; Carolyn M Hutter; Li Hsu; David J Duggan; Robert D Langer; Helen Petrovitch; James M Shikany; Thomas L Vaughan; Johanna W Lampe; Ross L Prentice; Ulrike Peters
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-15       Impact factor: 4.254

Review 3.  Nutrients Impact the Pathogenesis and Development of Colorectal Cancer.

Authors:  Wan Du; Jing-Yuan Fang
Journal:  Gastrointest Tumors       Date:  2015-10-10

Review 4.  Selenium for preventing cancer.

Authors:  Gabriele Dennert; Marcel Zwahlen; Maree Brinkman; Marco Vinceti; Maurice P A Zeegers; Markus Horneber
Journal:  Cochrane Database Syst Rev       Date:  2011-05-11

5.  Estrogen status alters tissue distribution and metabolism of selenium in female rats.

Authors:  Xiaodong Zhou; Anne M Smith; Mark L Failla; Kristina E Hill; Zhongtang Yu
Journal:  J Nutr Biochem       Date:  2011-06-17       Impact factor: 6.048

6.  Genetic variation in GPX1 is associated with GPX1 activity in a comprehensive analysis of genetic variations in selenoenzyme genes and their activity and oxidative stress in humans.

Authors:  Yumie Takata; Irena B King; Johanna W Lampe; Raymond F Burk; Kristina E Hill; Regina M Santella; Alan R Kristal; David J Duggan; Thomas L Vaughan; Ulrike Peters
Journal:  J Nutr       Date:  2012-01-18       Impact factor: 4.798

Review 7.  Selenium and cancer: biomarkers of selenium status and molecular action of selenium supplements.

Authors:  Jolanta Gromadzińska; Edyta Reszka; Katharina Bruzelius; Wojciech Wasowicz; Björn Akesson
Journal:  Eur J Nutr       Date:  2008-05       Impact factor: 5.614

Review 8.  Selenium and the prevention of prostate and colorectal cancer.

Authors:  Ulrike Peters; Yumie Takata
Journal:  Mol Nutr Food Res       Date:  2008-11       Impact factor: 5.914

9.  Sex-specific transcriptional responses of the zebrafish (Danio rerio) brain selenoproteome to acute sodium selenite supplementation.

Authors:  Maia J Benner; Matt L Settles; Gordon K Murdoch; Ronald W Hardy; Barrie D Robison
Journal:  Physiol Genomics       Date:  2013-06-04       Impact factor: 3.107

10.  Risk of breast cancer in relation to dietary intake of selenium and serum selenium as a marker of dietary intake: a prospective cohort study within The Malmö Diet and Cancer Study.

Authors:  Ylva Bengtsson; Malte Sandsveden; Jonas Manjer
Journal:  Cancer Causes Control       Date:  2021-04-29       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.